← back to search

Wenjuan Ma

Xinjiang Medical University · CN
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Advanced biosensing and bioanalysis techniques, RNA Interference and Gene Delivery, and Colorectal Cancer Treatments and Studies.
h-index
21
citations
2,070
works
67
NIH funding
primary concept
email

Recent publications

What drives the cooling dynamics of urban vegetation via evapotranspiration and shading under extreme heat?
Sustainable Cities and Society 2025cited by 14position: firstdoi
Optimizing Vegetation and Building Configurations for Streetscape Heat Mitigation: A Multi-Scale Analysis under Extreme Heat
Building and Environment 2025cited by 11position: firstdoi
Greening dominates greenspace exposure inequality in Chinese cities
npj Urban Sustainability 2025cited by 9position: middledoi
Vertical canopy structure dominates cooling and thermal comfort of urban pocket parks during hot summer days
Landscape and Urban Planning 2024cited by 94position: middledoi
Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients
Nature Communications 2024cited by 63position: middledoi
HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype
Journal for ImmunoTherapy of Cancer 2024cited by 14position: middledoi
Influence of TP53 mutation on efficacy and survival in advanced EGFR‐mutant non‐small cell lung cancer patients treated with third‐generation EGFR tyrosine kinase inhibitors
MedComm 2024cited by 5position: middledoi
The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation
Cellular and Molecular Immunology 2023cited by 65position: middledoi
Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors
Annals of Medicine 2023cited by 30position: middledoi
Biomimetic Nanoerythrosome‐Coated Aptamer–DNA Tetrahedron/Maytansine Conjugates: pH‐Responsive and Targeted Cytotoxicity for HER2‐Positive Breast Cancer
Advanced Materials 2022cited by 291position: firstdoi
HIF-1α inhibition promotes the efficacy of immune checkpoint blockade in the treatment of non-small cell lung cancer
Cancer Letters 2022cited by 89position: middledoi
Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway
Phytomedicine 2022cited by 58position: middledoi
Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma
Nature Cancer 2020cited by 134position: firstdoi
PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma
Nature Communications 2018cited by 153position: middledoi
Circulating Glioma Cells Exhibit Stem Cell-like Properties
Cancer Research 2018cited by 110position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jiaxin Cao · Jiangxi University of Water Resources and Electric Power5 papers (2022–2024)Yan Huang · Chinese PLA General Hospital5 papers (2022–2024)Fan Luo · Tongren Hospital5 papers (2022–2024)Jianhua Zhan · Sun Yat-sen University5 papers (2022–2024)Hongyun Zhao · Harbin University of Science and Technology4 papers (2022–2024)Zhaowu Yu · Fudan University4 papers (2024–2025)Feiteng Lu · Sun Yat-sen University4 papers (2022–2024)Yi Fan · Shandong University3 papers (2018–2020)Menggui Huang · Cleveland Clinic Lerner College of Medicine3 papers (2018–2020)Yunpeng Yang · CSPC Pharmaceutical Group3 papers (2023–2024)Jinyu Hu · Fudan University3 papers (2025–2025)Kangmei Zeng · Sun Yat-sen University3 papers (2022–2024)Donald M. O’Rourke · Parker Institute for Cancer Immunotherapy3 papers (2018–2020)Lin Zhang · Simon Fraser University3 papers (2018–2023)Yanqing Gong · Guangzhou University of Chinese Medicine3 papers (2018–2020)Chaozhuo Lin · Sun Yat-sen University3 papers (2023–2024)Haineng Xu · Wenzhou Medical University2 papers (2018–2018)Lusha Liu · Hebei Medical University2 papers (2023–2024)H.P. Zhang · Fudan University2 papers (2025–2025)Yuxia Hu · Fudan University2 papers (2025–2025)